Updated ENZARAD findings show no significant metastasis-free survival benefit with enzalutamide, although patients receiving pelvic lymph node radiation may benefit from intensification.
Lauren Banks, MD, PhD, explains early findings from a pilot study of lifileucel in dedifferentiated liposarcoma and undifferentiated pleomorphic sarcoma, including treatment feasibility, safety, and ...
Obesity and lung cancer research shows mixed results; experts urge moving beyond BMI to waist metrics and CT-based body ...
The FDA granted final approval to Alembic's generic venetoclax tablets, rated therapeutically equivalent to Venclexta, for CLL/SLL and newly diagnosed AML.
Merieme Klobocista, MD, explains how surgical history, disease burden, and body habits guide minimally invasive surgery decisions in gynecologic cancer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results